Healthcare Sector Selloff: VHT and XLV Buying Opportunity
The healthcare sector is experiencing significant corrections with BioNTech down 17.88% and Centene down 15.97%. This article explores healthcare ETF buying strategies and portfolio rebalancing methods using a rebalancing calculator.
Strong selling pressure is hitting the global healthcare sector. German biotech BioNTech (BNTX) plunged 17.88% to $83.89, while U.S. health insurer Centene (CNC) dropped 15.97% to $36.40. This simultaneous decline in major healthcare names reflects deteriorating sector sentiment and may present buying opportunities in healthcare ETFs like VHT and XLV.
Causes Behind the Biotech and Insurance Selloff
VHT vs XLV: Healthcare ETF Selection Guide
Investment Strategy During Healthcare Corrections
Defensive Portfolio and Healthcare ETF Allocation
Conclusion
The sharp healthcare sector correction may present buying opportunities for long-term investors. BioNTech and Centene's steep declines don't impair overall sector fundamentals, and VHT or XLV offer diversification against individual stock risk. Computing optimal weights with an asset allocation calculator and restoring target allocations with a rebalancing calculator represents disciplined investing that delivers better long-term results.
Related Portfolios
Related Articles
Apply with the Rebalancing Calculator
Automatically calculate exactly how much to buy and sell to rebalance your portfolio.
Start Rebalancing CalculatorHave any questions?
